RG-001(RinuaGene)

N/A

Report date: 2024/12/09 16:33:07

Base Information

Drug NameRG-001(RinuaGene)
Drug Alias NameRG-001(RinuaGene)RG001(RinuaGene)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesRenjing (Suzhou) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRenjing (Suzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A